Note that the N for the clinical and laboratory data is smaller because only those data collected within 6 months of the biopsy were included. All participants in the cohort are included for the data on histology. ∆ NAS -2.0 ‡ 1.8 -0.8 ‡ 1.7 -0.2 ‡ 1.9 <0.001 * P for trend. Analysis limited to subset of 218 participants with non-missing weight measurements within 6 months of biopsy (one participant was missing weight measurement at second biopsy).
NAS=Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score (sum of scores for steatosis, lobular inflammation, and ballooning, range 0-8)
